Cancer · 1994
Long survival in patients with acquired immune deficiency syndrome-related primary central nervous system lymphoma.
Клинический случайСтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Chamberlain M C
Аннотация
BACKGROUND: Primary central nervous system lymphoma (PCNSL) is the most common brain tumor occurring in patients with acquired immune deficiency syndrome (AIDS). After diagnosis of PCNSL, the median survival time is 2-5 months with treatment with whole brain irradiation (WBI).
METHODS: Four (of approximately 40) patients with AIDS and PCNSL seen by the University of California, San Diego (UCSD) Neuro-Oncology service were treated with multimodal therapy, including WBI with hydroxyurea, followed by 3 cycles of procarbazine/lomustine/vincristine (PCV) chemotherapy.
RESULTS: Survival after tumor diagnosis ranged from 11 to 16 months, with a median of 13.5 months.
CONCLUSION: Selected patients with AIDS and PCNSL may have long survival when treated with multimodal therapy.
METHODS: Four (of approximately 40) patients with AIDS and PCNSL seen by the University of California, San Diego (UCSD) Neuro-Oncology service were treated with multimodal therapy, including WBI with hydroxyurea, followed by 3 cycles of procarbazine/lomustine/vincristine (PCV) chemotherapy.
RESULTS: Survival after tumor diagnosis ranged from 11 to 16 months, with a median of 13.5 months.
CONCLUSION: Selected patients with AIDS and PCNSL may have long survival when treated with multimodal therapy.